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TGF-βTransforming growth factor-β (TGF-β) inducesmiR-21 expressionwhich contributes to ﬁbrotic events in the left
ventricle (LV) under pressure overload. SMAD effectors of TGF-β signaling interact with DROSHA to promote pri-
marymiR-21 processing into precursor miR-21 (pre-miR-21).We hypothesize that p-SMAD-2 and -3 also inter-
act with DICER1 to regulate the processing of pre-miR-21 to mature miR-21 in cardiac ﬁbroblasts under
experimental and clinical pressure overload. The subjects of the study were mice undergoing transverse aortic
constriction (TAC) and patients with aortic stenosis (AS). In vitro, NIH-3T3 ﬁbroblasts transfected with pre-
miR-21 responded to TGF-β1 stimulation by overexpressing miR-21. Overexpression and silencing of SMAD2/3
resulted in higher and lower production of mature miR-21, respectively. DICER1 co-precipitated along with
SMAD2/3 and both proteins were up-regulated in the LV from TAC-mice. Pre-miR-21 was isolated bound to
the DICER1 maturation complex. Immunoﬂuorescence analysis revealed co-localization of p-SMAD2/3 and
DICER1 in NIH-3T3 and mouse cardiac ﬁbroblasts. DICER1-p-SMAD2/3 protein–protein interaction was con-
ﬁrmed by in situ proximity ligation assay. Myocardial up-regulation of DICER1 constituted a response to pressure
overload in TAC-mice. DICERmRNA levels correlated directlywith those of TGF-β1, SMAD2 and SMAD3. In the LV
from AS patients, DICER mRNA was up-regulated and its transcript levels correlated directly with TGF-β1,
SMAD2, and SMAD3. Our results support that p-SMAD2/3 interactswith DICER1 to promote pre-miR-21 process-
ing tomaturemiR-21. This new TGFβ-dependent regulatorymechanism is involved inmiR-21 overexpression in
cultured ﬁbroblasts, and in the pressure overloaded LV of mice and human patients.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
The left ventricle (LV), when subjected to chronic hemodynamic
stress as occurs in valvular aortic stenosis (AS) or hypertension, un-
dergoes a pathological remodeling process, which is characterized by
the hypertrophic growth of cardiomyocytes and accumulation of extra-
cellular matrix proteins in the myocardium. The resulting structuralBI,BMPandactivinmembrane-
ion 8; LV, left ventricle; miRNA,
, microRNA primary transcript;
C, transverse aortic constriction;
43; TGF-β, transforming growth
tein
ía y Farmacología, Facultad de
Spain. Tel.: +34 942 201 981;changes contribute to the development of contractile dysfunction,
which evolves to heart failure [1].
MicroRNAs (miRNAs) are noncoding single-stranded RNAs, approx-
imately 22 nucleotides (nt) in length that are involved in the post-
transcriptional control of gene expression [2]. MiRNA genes are usually
transcribed by RNA polymerase II, and a single primary transcript of
miRNA (pri-miRNA) may contain various miRNA precursors [3]. The
biogenesis of speciﬁc functionalmiRNAs requires a two-stepmaturation
process. The RNase DROSHA initiates miRNA maturation in the nucleus
by cleavage of the stem loops of pri-miRNAs that are converted into
~70 nt hairpin precursors (pre-miRNAs) [4]. DROSHA forms a macro-
molecular protein assembly (termed Microprocessor complex) with
DiGeorge Syndrome Critical Region 8 (DGCR8) and several cofactors,
which are crucial for the accuracy and activity of DROSHA cleavage [4,
5]. After transport to the cytoplasm, pre-miRNAs undergo a further pro-
cessing step mediated by the RNase DICER, which generates a duplex
miRNA/miRNA* of 19–25 nt [6]. DICER interacts with different partners
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proteins [7,8]. One strand of the mature miRNA together with Ago is
loaded into the RNA-induced silencing complex (RISC) and helps in
the guidance of RISC to target mRNAs [9]. MiRNAs interact with their
cognate mRNAs leading to their translational repression and/or degra-
dation [9].
These small non-coding RNAs have emerged as major regulators of
cellular processes involved in the developmental biology, physiology
and pathology of the cardiovascular system, with potential clinical ap-
plications [10–12]. The harmonious interplay between the miRNAs
expressed by the heart is a requirement to keep balanced cardiac mor-
phology, structure and function [13,14]. Speciﬁc miRNAs have been im-
plicated in the progression of heart diseases [10] and miR-21 is one of
themost consistently up-regulated during cardiac biomechanical stress
in experimental models and human pathologies [13–16,21].
Transforming growth factor (TGF-β) plays crucial pathophysiologi-
cal roles in themaladaptive remodeling of the heart in response to pres-
sure overload by triggering interstitial ﬁbrosis and cardiomyocyte
hypertrophic growth [17–19]. Several reports provide evidence that
miR-21 acts as a downstream effector of TGF-β signaling to expand
pathological ﬁbrosis in different tissues [20,21]. In the myocardium
under biomechanical stress, TGF-β induces miR-21 up-regulation,
which contributes to maladaptive remodeling both in mice [15] and in
AS patients [22]. Davis et al. [23,24] investigated the molecular path-
ways underlying TGF-β-mediated induction of miR-21 in vascular
smooth muscle cells (VSMCs), and showed that the SMAD2/3 canonical
effectors of TGF-β signaling promote post-transcriptional cleavage of
pri-miR-21 into pre-miR-21 by DROSHA. SMADs bind RNA-SMAD bind-
ing element (R-SBE)within the stem region of theprimary transcripts of
miRNAs regulated by TGF-β, which is similar to the SBE found in the
promoters of TGF-β target-genes [23–25]. However, the potential role
for TGF-β signaling in the cleavage of pre-miR21 by the ribonuclease
III DICER1 remains hitherto unexplored.
Herein, we assess the role of the TGF-β signaling effectors SMAD2/3
in the processing of pre-miR-21 by DICER1 to yieldmaturemiR-21 in ﬁ-
broblasts. We also explored the functional coupling between activated
SMAD2/3 and DICER1 to control the biogenesis of miR-21 during the
LV remodeling response to pressure overload inmice subjected to trans-
verse aortic constriction (TAC). The clinical relevance of such interaction
was conﬁrmed in LV biopsies from severe AS patients.
2. Methods
2.1. Pressure overload studies in mice
Adult (16–20 weeks old) C57BL6 mice were housed in a room kept
at 22 °C with 12:12 h light/dark cycle and provided with standard
food and water ad libitum. The study was approved by the University
of Cantabria Institutional Laboratory Animal Care and Use Committee
and conducted in accordance with the “European Directive for the Pro-
tection of Vertebrate Animals Used for Experimental andOther Scientif-
ic Purposes” (European Communities Council Directive 86/606/EEC).
LV pressure overload was induced by transverse aortic constriction
(TAC). Themice (n= 5 to 12 per group)were anesthetized by intraper-
itoneal injection of ketamine (10mg/kg) and xylazine (15mg/kg) as de-
scribed [15]. They were subjected to TAC or sham surgery and
euthanized 6 h, 12 h or 2 weeks after surgery.
2.2. Pressure overload studies in patients
The study followed the Declaration of Helsinki guidelines for bio-
medical research involving human subjects. The institutional ethics
and clinical research committee approved the study, and all patients
gavewritten informed consent. The clinical and demographic character-
istics of the AS and control groups are shown in Supplemental Table S1.
The study was performed using LV myocardial intraoperative biopsiesobtained froma cohort of 67 consecutive patients diagnosedwith isolat-
ed severe AS and undergoing aortic valve replacement surgery in the
University Hospital Marqués de Valdecilla in Santander, Spain. Patients
with aortic or mitral regurgitation greater than mild or with major cor-
onary stenosis greater than 50%, previous cardiac operations, malignan-
cies or poor renal or hepatic function were deemed ineligible for the
study. The control group for comparing themyocardial gene expression
was a cohort of 30 surgical patients with pathologies (atrial septal de-
fect: n = 18, aortic aneurysm: n = 6, mitral stenosis: n = 3, left atrial
myxoma: n=2, pulmonary valve ﬁbroelastoma: n=1) that did not in-
clude pressure or volume overload, coronary heart disease or cardiomy-
opathies. Subepicardial biopsies (4 to 10 mg) were taken from the LV
lateral wall with a Tru‐cut needle during the surgical procedure and
snap frozen in liquid nitrogen.
2.3. NIH-3 T3 cell culture
NIH-3 T3 ﬁbroblasts (ATCC, USA) were cultured in Dulbecco’s Mod-
iﬁed Eagle's Medium (DMEM) supplemented with 10% FBS (Biological
Industries, Israel), 100 U/ml penicillin-streptomycin, at 37 °C in 5%
CO2. The cells (2 x 105) were plated in 35 mm culture dish and, 24 h
later, they were transiently transfected with pre-miR-21 (1 and
10 nM) or control miRNA (Ambion, Inc) using X-tremeGENE 9 DNA
transfection reagent (Roche Diagnostics, Germany). In a series of exper-
iments, the cells were transfected with siSMAD2/3 or scrambled siRNA
(Santa Cruz Biotech. Inc), pCIG-ORF-SMAD2 (0.6 μg/ml), pCIG-ORF-
SMAD3 (0.6 μg/ml) or empty pCIG vector (1.2 μg/ml; kindly given by
Dr. Martí (Parc Cientiﬁc, Barcelona, Spain)). In another series of assays,
SIS3 (selective inhibitor of SMAD3; Calbiochem), and SB431542 [specif-
ic inhibitor of the TGF-β type 1 receptors ALK4, ALK5 and ALK7; (Sigma
Aldrich)], were used to block SMAD3 and SMAD2/3, respectively.
Four hours later, cells were incubated with recombinant TGF-β1
(0.30 ng/ml) (R&D Systems) for 24 h. The experiments were performed
in triplicate and repeated on three separate occasions.
2.4. Luciferase reporter assays
NIH 3T3 cells were seeded in 96 well plates (2 × 104/well) and cul-
tured in the presence of recombinant TGF-β1 (0.3 ng/ml) for 24 h.
Cells were co-transfected with a mixture of miR-21 (10 nM), or scram-
bled miRNA (Ambion, Inc), and pMIR-reporter luciferase vector con-
taining the 3′-UTR of TGF-β1 or SMAD7 in the pMIR-reporter β-Gal
(β-galactosidase) vector (50 ng), using X-tremeGENE 9 DNA transfec-
tion reagent (Roche Diagnostics, Germany). Luciferase activity was
assessed after 24 h using a Luciferase® Reporter Assay System
(Promega) according to the manufacturer's speciﬁcations. Transfection
and luciferase assays were performed in triplicate and repeated on
three separate occasions.
2.5. Primary culture of mouse cardiac ﬁbroblasts
Adult cardiac ﬁbroblasts were isolated from 4 month-old C57BL6
mice by enzymatic digestion as previously described [15]. For experi-
mental procedures, low passage cells (p2) were seeded onto 35 mm
cell culture dishes and incubated at 37 °C, in 5% CO2, for 15–20 h. The
cells were growth arrested by incubation in DMEM containing 10%
FBS and 10% DBS for 12 h.
2.6. MiR-21 detection by in situ hybridization
MiR-21 in situ hybridizationwas conducted inNIH-3T3 cells and pri-
mary cardiac ﬁbroblasts usingmiCURY LNAmiRNA ISH Kit (Exiqon A/S,
Vedbaek, Denmark), which contains a digoxigenin (DIG)-double-la-
beled speciﬁc miR-21 probe (5′-DIG/TCA ACA TCA GTC TGA TAA GCT
A/DIG-3′), and a scrambled miRNA probe (5′-DIG/GTG TAA CAC GTC
TAT ACG CCC A/DIG-3′) to be used as negative control.
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Fixed NIH-3 T3 cells, primary cardiac ﬁbroblasts and LV sections
from TAC mice were incubated overnight with primary antibodies
against p-SMAD2/3 (Santa Cruz) and DICER1 (Abcam). Secondary anti-
bodies were conjugated with FITC (Jackson, USA) or Cy3 (Abcam). DAPI
(Sigma) was used as a nuclear counterstain. Confocal microscopy was
performed with an LSM-510 laser scanning microscope (Carl Zeiss
Inc., Germany) using a 40× objective.
2.8. In situ proximity ligation assay
We utilized the Duolink kit for in situ proximity ligation assay
(Duolink II, Sigma), following the manufacturer's instructions on NIH-
3 T3 cells treated with TGFβ1 (0.3 ng/ml) for 24 h, ﬁxed in paraformal-
dehyde (4%) and permeabilized with 0.25% Triton-X.
Primary antibodies utilized: rabbit polyclonal anti DICER1 (Abcam),
goat polyclonal anti p-SMAD2/3 (Santa Cruz), goat polyclonal anti p-
SMAD2 (Santa Cruz), rabbit polyclonal anti p-SMAD3 (Abcam), goat
polyclonal anti TGF-β (Santa Cruz) and rabbit polyclonal anti Elk1
(Santa Cruz). Secondary antibodies bear a short DNA strand that hybrid-
izeswith anadditional circle-formingoligodeoxynucleotide [26,27]. The
DNA is then visualized using a ﬂuorescent probe using a Nikon A1Rmi-
croscope, with a plan apochromatic 60 × 1.4 NA objective operated by
the Nis elements software.
2.9. Determination of mRNA and miRNA expressions by q-PCR
Total RNA from the LVmyocardium and cultured cells was obtained
by TRIzol extraction (Invitrogen). MiRNAs were isolated using a miRNA
isolation kit (Nucleo spin miRNA kit, Macherey-Nagel, Germany). The
mRNA was reverse transcribed using random primers and the miRNAs
were reversed transcribed using speciﬁc primers for pre-miR-21, miR-
21, cel-miR-39 and RNU6-b (Applied Biosystems). The quantitative
PCR (Q-PCR) was performed with speciﬁc TaqMan primers: DICER1,
TGF-β1, SMAD2, SMAD3, TIMP3, TGF-βR2, miR-21 and SYBR Green
primers for pre-miR-21: reverse, 5′-TGTCAGACAGCCCATCGACT-3′ for-
ward, 5′-TGTCGGGTAGCTTATCAGAC-3′ (Sigma-Aldrich). The house-
keeping genes were cel-miR-39, 18S and RNU6b. Duplicate transcript
levels were determined in a minimum of three independent
experiments.
To avoid the confounding inﬂuence of factors such as anesthesia,
surgery, inﬂammation, etc., in the group of mice subjected to 6–12 h
TAC,mRNA andmiRNA relative expressions (vs 18S and RNU6B, respec-
tively) were expressed as fold change in TAC mice versus the average
expression of sham operated mice.
2.10. MicroRNA-21 Northern blot analysis
Total RNA (5 μg) was resolved in a 15% polyacrylamide gel and blot-
ted onto a Hybond-N+ nylon membrane (Amersham Biosciences).
miRCURY LNA™ microRNA detection probe for hsa-miR-21 was pur-
chased from Exiqon. The oligonucleotide sequence (5′-TCAACATCAG
TCTGATAAGCTA-3′), which is complementary to mature miR-21, was
end labeled with [α-32P]ATP and T4 polynucleotide kinase (New
England BioLabs) to generate highly-speciﬁc-activity probes. The oligo-
nucleotide sequence for 5S rRNA was 5′-CAGGCCCGACCCTGCTTAGCTT
CCGAGATCAGACGAGAT-3′. Hybridization was carried out according to
Express Hyb (Bio-Rad) protocols.
2.11. RNA-immunoprecipitation assays
Polyclonal SMAD2/3 antibody was incubated with Dynabeads pro-
tein G (Dynal Biotech, invitrogen), following the manufacturer's proto-
col. Controls were performed using non-speciﬁc IgG-Dynabeads. LV
samples were homogenized and lysed in buffer (Tris 50 mM, EDTA1 mM, SDS 2%) containing a protease inhibitor cocktail (Sigma-Aldrich,
pH 7.5). Lysates were incubated with SMAD2/3 Ab-Dynabeads and the
eluentwas processed forWestern blot analysis and for RNA puriﬁcation
using TRIzol reagent. Twenty-ﬁve fentomoles of Caenorhabditis elegans
oligonucleotide (cel-miR-39) were added as a spike-in control [28].
Pre-miR-21 and miR-21 expression levels were determined by q-PCR
and normalized to cel-miR-39.
2.12. Protein detection by Western Blot
Samples were resolved on 10% sodium dodecyl sulfate-
polyacrylamide (SDS-PAGE) gel and transferred onto polyvinylidene
diﬂuoride (PVDF) membranes (Bio-Rad Lab., California, USA). The pri-
mary antibodies used were: monoclonal anti DICER (Abcam); polyclon-
al anti p-SMAD2/3 (Santa Cruz); polyclonal anti GAPDH (Santa Cruz);
and polyclonal anti ELK-1 (Santa Cruz). ECL Advance Western Blotting
Detection Kit (GE Healthcare Europe GmbH, Munich, Germany) was
used for immunodetection.
2.13. Statistics
The data sets were assessed for normality with the Kolmogorov–
Smirnov test. Continuous variables were compared using two-tailed
Student's t-test or Mann–Whitney U test. Correlations between the
expression levels of miR-21 and cardiac remodeling genes were
performed using Pearson's correlation analysis. Statistical packages:
GraphPad Prism 5.03 and PASW Statistics 18 (SPSS Inc., Chicago, IL).
3. Results
3.1. p-SMAD2/3 proteins participate in the maturation of pre-miR-21 to
miR-21 upon TGF-β1 stimulation
The SMAD effectors of TGF-β signaling control the transcription of
pri-miR-21 and its subsequent post-transcriptional nuclear conversion
into pre-miR-21 [23,29]. Herein, we assessed whether p-SMAD2/3 reg-
ulates also the last step of miR-21maturation, i.e. the processing of pre-
miR-21 to mature miR-21. For this purpose, NIH-3 T3 ﬁbroblasts were
transfected with pre-miR-21, SMAD2/3 and siSMAD2/3 and the expres-
sion levels of pre-miR-21 and miR-21 were detected by Northern blot
(Fig. 1A). Concomitant transfection of the cells with pre-miR-21
(10 nM) and pCIG-ORF-SMAD2 (0.6 μg/ml) and pCIG-ORF-SMAD3
(0.6 μg/ml) increased the production of mature miR-21 (1.7 ± 0.2 fold
vs control, p b 0.01; Fig. 1A lane 3, and densitogram in Fig. 1C), while
the expression of its precursor was reduced (0.6 ± 0.2 fold vs control,
p b 0.05; Fig. 1A lane 3, and densitogram in Fig. 1B). Silencing SMADs
with siRNAs (10 nM) prevented the overproduction of mature miR-21
induced by pCIG-ORF-SMAD2 and pCIG-ORF-SMAD3 (0.9 ± 0.1 fold vs
control; Fig. 1A lane 4, and densitogram in Fig. 1C) and consequently,
pre-miR-21 expression increased (2.1 ± 0.2 fold vs. control, p b 0.001;
Fig. 1A lane 4, and densitogram in Fig. 1B). Western blot experiments
conﬁrmed the reduction of SMAD2/3 protein expression in cells treated
with siSMAD2/3 (Fig. 1F and densitograms in Fig. 1H and I), which re-
sulted in miR-21 down-regulation and pre-miR-21 accumulation as de-
termined by qPCR (Fig. 1D and D′). The expression of DICER1 protein
was not altered after silencing SMAD2/3; therefore, the impaired pro-
cessing of miR-21 by the cells was not due to reduced expression of
DICER1 (Fig. 1F and densitogram in Fig. 1G). Chemical inhibition of
SMAD2 and SMAD3 with SB431542 conﬁrmed the reduction of miR-
21 production and the accumulation of pre-miR-21 observed after
knocking-down SMAD2/3 using siRNAs (Fig. 1 E and E′). Of note, the se-
lective inhibition of SMAD3with SIS3 produced a similar degree of miR-
21 down-regulation to the inhibition of both SMADs with SB431542.
These results, although they do not exclude a role for SMAD2, suggest
a preeminent contribution of SMAD3 to the TGF-β-dependent regula-
tion of DICER1 endonuclease activity.
Fig. 1.A:Representative Northernblot showing the expression levels of pre-miR-21 andmiR-21 inNIH-3 T3 cells cultured in thepresence of TGF-β1. Cellswere non-transfected (lane 1) or
transfectedwith pre-miR-21 (lanes 2, 3 and 4), SMAD2+SMAD3 (lanes 3 and 4) and siSMAD2/3 (lane 4). 5S rRNAwas used as a loading control. The blots belong to the same gel. B and C:
Densitograms of pre-miR-21 (B) andmiR-21 (C) expression as relative fold change vs. non transfected cells (open column of the histograms). D and E: Effects of recombinant TGF-β1 on
mature miR-21 (D and E) and pre-miR-21 (D′ and E′) expression levels, determined in the same cells. Knocking-down SMAD2/3 with siSMAD2/3 or chemical inhibition with SB431542
resulted in lower production of mature miR-21 and accumulation of pre-miR-21. Similar effects were observed with the selective chemical inhibitor of SMAD3, SIS3. F: Representative
Western blots showing the protein levels of DICER1, SMAD2/3 and p-SMAD2/3 in NIH-3 T3 cells transfected with pre-miR-21 or scrambled oligonucleotides and siSmad2/3 or scrambled
siRNA. GAPDHwas used as loading control. G, H and I: Densitograms of DICER1 (G), SMAD2/3 (H) and p-SMAD2/3 (I) protein expression as relative fold change vs. control cells (ﬁrst dot of
eachWestern blot) (*p b 0.05, **p b 0.01, ***p b 0.001, ANOVA followed by Bonferroni).
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in this particular cell linewas already reported [22]. After cell activation
with TGF-β1 (0.3 ng/ml), the maximal overexpression of SMAD2/3 and
its active form p-SMAD2/3 was observed at 24 h (supplementary Fig
S1). Moreover, an increment in pre-miR-21 levels resulted in a signiﬁ-
cant increase in mature miR-21 (supplementary Fig S2). Overall, our
in vitro results support the involvement of active SMAD2/3 (phosphor-
ylated form) in the processing of pre-miR-21 to mature miR-21 by
DICER1 in NIH-3 T3 ﬁbroblasts (a schematic representation of this pro-
cess is depicted in Fig. 7).3.2. p-SMAD2/3 physically interacts with DICER1 within NIH-3 T3 cells
To determinewhether p-SMAD2/3 and DICER1 co-localize in similar
cellular compartments we performed confocal immunoﬂuorescence
analysis in NIH-3 T3 ﬁbroblasts treated with recombinant TGF-β1. The
results revealed a marked co-localization of p-SMAD2/3 and DICER1
ﬂuorescence signals in the perinuclear region, suggesting that DICER1
and p-SMAD2/3 might interact in the same functional complex
(Fig. 2A). We further assessed whether p-SMAD2/3 interacts directly
and speciﬁcally with DICER1 using in situ proximity ligation assay
Fig. 2.DICER1 and p-SMAD2/3 co-localize inNIH-3T3 ﬁbroblasts. A: Representative confocal immunoﬂuorescence images showingDICER1 (red) andp-SMAD2/3 (green) inNIH-3 T3 cells.
Themerged panel showsDICER1/p-SMAD2/3 co-localization (yellow). B, C andD: In situ protein–protein association betweenDICER1 andp-SMAD2/3 detectedbyproximity ligation assay
(PLA). B: Proximity ligation signals (red) in NIH-3 T3 cells using rabbit polyclonal anti-DICER1 and goat polyclonal anti-p-SMAD2/3 antibodies. Nuclei were counterstained with DAPI
(blue). Each red dot represents a protein–protein association complex. C: Positive control experiment using goat polyclonal anti-p-SMAD3 and rabbit polyclonal anti-p-SMAD2 antibodies.
D: Negative control experiment using primary antibodies directed against non-interacting proteins such as ELK-1 and TGF-β.
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investigated proteins in an expected interaction (i.e. DICER1 and p-
SMAD2/3). As shown in Fig. 2B, in situ proximity ligation assay gave a
bright signal within the spots where DICER1 and p-SMAD2/3 presented
a physical interaction. The perinuclear localization of the PLA ﬂuores-
cence is in agreement with the confocal immunoﬂuorescence observa-
tions. Taken together, our results demonstrate the capability of p-
SMAD2/3 to physically interact with DICER1 to form protein-protein
complexes in NIH-3T3 cells (a schematic representation is shown in
Fig. 7). The positive control showed p-SMAD2/p-SMAD3 complexes
scattered in both the nucleus and cytoplasm of the cells. No positive
signal was detected using primary antibodies directed against non-
interacting proteins such as ELK-1 and TGF-β as a negative control.Fig. 3. SMAD7, but not TGF-β1, is targeted bymiR-21. A and B: Luciferase activity of the 3′-untra
T3 cells co-transfected withmiR-21mimics or with scrambled oligonucleotides (scr-oligos) as n
in cells transfected with TGF-β1 3′UTR while in the positive control miR-21 markedly reduces3.3. miR-21 targets 3′UTR of SMAD7 but not 3′UTR of TGF-β1 in NIH-3 T3
cells
Our ﬁndings alongwith previously published work [23–25] indicate
that the miR-21 maturation process is tightly regulated by canonical p-
SMAD2/3. In turn, several elements of TGF-β pathways are targeted by
miR-21 [19,29]. To assess whether TGF-β1 can establish a negative
auto-regulatory feed-back loop mediated by miR-21 in ﬁbroblasts, we
determined the capability of miR-21 to target the transcripts of TGF-
β1. For this purpose, the interaction of miR-21 with the 3′-untranslated
region (3′UTR) of TGF-β1 was determined using a luciferase assay in
NIH-3 T3 cells. As a positive control, cells were transfected with the 3′
UTR of SMAD7, an inhibitory element of the TGF-β signaling, whichnslated region (3′UTR) of human TGF-β1 (A) and the 3′UTR of human SMAD7 (B) inNIH-3
egative control. The luciferase assay shows that miR-21 does not reduce luciferase activity
luciferase activity in cells transfected with SMAD7 3′UTR (**p b 0.01, Student's t test).
1525R. García et al. / Biochimica et Biophysica Acta 1852 (2015) 1520–1530has been previously reported to be a target of miR-21 in other cell types
[19] but not yet in ﬁbroblasts. The luciferase assays (n= 4 independent
assays) showed that transfection of miR-21 only reduced the luciferase
activity in cells transfected with the 3′UTR of SMAD7, but not in cells
overexpressing the 3′UTR of TGF-β1 (Fig. 3).
3.4. Myocardial up-regulation of DICER1 constitutes a LV remodeling
response to pressure overload in mice which is directly related to the
expression levels of TGF-β1 and its canonical effectors
Next, we hypothesized that TGF-β1 and DICER1 may function
together to control miR-21 maturation during the LV remodeling re-
sponse to pressure overload in mice subjected to TAC. The echocardio-
graphic morphofunctional changes induced by 2 weeks of TAC in mice
are depicted in Supplementary Fig. S3.
Our previous [22] and present results (Supplementary Table S2)
showed increased expression levels of miR-21 in the pressure
overloaded myocardium from TAC mice both in the early (6 and 12 h-
TAC) and late (2-week-TAC) phases following aortic constriction, in
comparison with the corresponding sham group of mice. In parallel,
the transcript levels of TGF-β1 and its canonical effectors (SMAD2
and/or SMAD3) increased signiﬁcantly after TAC (Supplementary
Table S2). The relevance of miR-21 overexpression in the remodeling
response to pressure overload was supported by the signiﬁcant and di-
rect correlation between miR-21 levels and the LV mass (R = 0.65,
p b 0.001) and with the expression levels of extracellular matrix ele-
ments such as Col I (0.55, p b 0.01) and FN1 (0.69, p b 0.001) observed
in 2-week-TAC mice (Supplementary Table S3).
The myocardial levels of DICER1 mRNA were signiﬁcantly up-
regulated in TACmice (Fig. 4 A andA′). DICER1 overexpression correlat-
ed signiﬁcantly and positively with the expression levels of genes
encoding TGF-β1 and its canonical effectors SMAD2 and SMAD3 both
in the early (6–12 h) and late (2 weeks) TAC mice (Fig. 4B–E). Of note,
the relationship between the early DICER1 expression and the rise in
TGF-β signaling triggered by pressure overload was further supported
by the results of multiple regression analysis. In the resulting model,
the transcript levels of TGF-β1, SMAD2 and SMAD3 constituted inde-
pendent predictors of myocardial DICER1 expression. The regression
equation was the following:
DICER1 ¼−1:25þ 0:55 SMAD2½  þ 0:31 SMAD3½  þ 0:19 TGF−β1½ :
The adjusted coefﬁcient of determination R2 (0.70; p b 0.001) indi-
cated that 70% of the variance in DICER1 mRNA levels during the ﬁrst
6–12 h after TAC could be estimated from this model [29]. Additionally,
in agreement with our hypothesis, the transcript levels of DICER1 and
pre-miR-21 were directly correlated (Fig. 4F, r = 0.56; p b 0.05).
3.5. The LV myocardium from aortic stenosis patients exhibits overexpres-
sion of DICER1 mRNA that is directly related to the expression of TGF-β1
and its canonical effectors
In order to establish the clinical relevance of the results obtained in
the pressure overload murine model and their translational potential,
we analyzed the relationship between DICER1 mRNA expression and
TGF-β signaling in LV biopsies obtained from a cohort of 64 severe AS
patients (Supplementary Table S1). As observed in TAC mice, the LV
myocardium from AS patients, compared with surgical controls, exhib-
ited increased expression levels ofmiR-21 and pre-miR-21, DICER 1 and
TGF-β1 (Supplementary Table S2 and Fig. 5A). Moreover, similar to our
ﬁndings in mice, DICER1mRNAmaintained signiﬁcant positive correla-
tions (Fig. 5B–E) with the expression of genes encoding TGF-β1 (r =
0.47; p b 0.001), SMAD2 (r = 0.48; p b 0.001) and SMAD3 (r = 0.54;
p b 0.001), as well as with pre-miR-21 (r = 0.34; p b 0.01).3.6. SMAD2/3 andDICER1 interact in the protein complex that regulates the
processing of pre-miR-21 in pressure-overloaded mice heart
The co-localization of p-SMAD2/3 and DICER1 that was observed in
NIH-3T3 ﬁbroblasts was also assessed in primary ﬁbroblasts from
adult C57BL6 mouse hearts incubated in the presence of TGF-β1 and
in LV sections from TAC mice. Mature miR-21 was expressed when pri-
mary LV ﬁbroblasts were cultured in the presence of recombinant TGF-
β1 (0.3 ng/ml), as evidenced by in situ hybridization (Fig. 6A). We also
conﬁrmed by confocal immunoﬂuorescence the co-localization of p-
SMAD2/3 and DICER1 in the perinuclear region of LV ﬁbroblast in cul-
ture (Fig. 6B) and in LV sections from TAC mice (Fig. 6C). Therefore,
we postulated that, under biomechanical stress, activated SMAD2/3
and DICER1 could interact within the protein complex that regulates
the processing of pre-miR-21. To assess this hypothesis, we performed
co-immunoprecipitation–RT-qPCR studies in LV myocardial lysates
from mice subjected to TAC pressure overload or sham operated,
using an antibody that targets SMAD2/3. We found that DICER1 co-
precipitated along with SMAD2/3, and both proteins were signiﬁcantly
up-regulated in the lysates from TAC-mice compared to sham-mice
(Fig. 6D–G). RNA bound to the protein complexes was isolated, and
a signiﬁcant increase of pre-miR-21 in TAC vs. sham mice (Fig. 6H)
was observed. When anti-SMAD2/3 antibody was substituted by a
non-speciﬁc IgG in control assays, pre-miR-21 was absent of the
immunoprecipitated complexes (data not shown). Densitometry
showed a 2.1 fold increase of DICER1 (Fig. 6E sham IP 2.6 ± 0.4 AU vs
TAC IP 4.2 ± 0.4 AU, p b 0.01 Student's t test) and a 1.6 fold increase
of SMAD2/3 (Fig. 6F sham IP 1.7 ± 0.1 AU vs TAC IP 2.4 ± 0.3 AU,
*p b 0.05, **p b 0.01 Student's t test) expression compared to sham
mice. Densitometry of the input is shown in Fig. 6G.
4. Discussion
In the present study, we provide evidence supporting a previously
uncharacterized role for the canonical TGF-β signaling pathway in the
posttranscriptional processing of pre-miR-21 into mature miR-21,
through the interaction of p-SMAD2/3 effectors with the DICER1 pro-
cessor machinery in ﬁbroblasts. The pathophysiological relevance of
this regulatory mechanism in the maladaptive remodeling response of
the LV myocardium to pressure overload is supported by our ﬁndings
in experimental mouse TACmodels and in the clinical scenario of aortic
valve stenosis.
The control of miRNA biogenesis by TGF-β signaling pathways is an
integral step of numerous cellular biological systems under physiologi-
cal and pathological conditions [29]. TGF-β inducesmiR-21 overexpres-
sion, which contributes to myocardial proﬁbrotic events in murine
models [15] and in patients [22]. The canonical effectors of TGF-β signal-
ing control the nuclear steps of miR-21 biogenesis. p-SMAD2 and
p-SMAD3 promote transcriptional activation of pri-miR-21 [29] and
regulate the subsequent post-transcriptional conversion of pri-miR-21
into pre-miR-21 by DROSHA [25,29]. Herein, we show that NIH-3T3 ﬁ-
broblasts responded to TGF-β1 stimulation leading to mature miR-21
up-regulation. With the purpose of dissecting the regulatory role of
TGF-β signaling on the last step of miR-21 maturation (from pre-miR-
21 to miR-21) by the RNase DICER1, NIH-3 T3 ﬁbroblasts were lipid-
transfected with the substrate of this reaction, i.e. pre-miR-21. Under
these experimental conditions, the cells exhibited an increased produc-
tion of mature miR-21 at a rate that was dependent on the amount of
pre-miR-21 transfected. Moreover, overexpression of pre-miR-21 and
SMAD2/3 resulted in an increased expression of miR-21, which was
accompanied by a reduction of the precursor. Conversely, down-
regulation of SMAD2/3 proteins was associated with a signiﬁcantly
lower production of mature miR-21 and an accumulation of pre-miR-
21 within the cells. Such phenomena occurred without any variation
in DICER1 expression after SMAD2/3 deregulation. Overall, our results
indicate a relevant regulatory role for SMAD2/3 in thematuring process
Fig. 4.Pressure overload inducesDICER1up-regulation in the LVofmice subjected to transverse aortic constriction (TAC). A:DICER1 gene relative expression (RE, normalized to 18S) in the
LVmyocardium from 2week-TAC and shamoperatedmice (***p b 0.001 vs. sham,Mann–Whitney test). A′: RepresentativeWestern blots showing DICER1 protein up-regulation in the LV
from 2 week-TAC mice. B to E: Linear regression and Pearson's correlation analyses showing the positive correlation between myocardial DICER1 mRNA and TGF-β1 (B), SMAD2 (C),
SMAD3 (D), and pre-miR-21 expression (E) in TAC mice. B to E: In the group of early TAC (6 h and 12 h), gene expression is presented as fold change in TAC mice versus the mean ex-
pression of their corresponding group of shammice. B′ to E′: In the group of 2-week-TAC, gene expression is presented as relative expression (RE) versus 18S ribosomal RNA. r= Pearson's
correlation coefﬁcient.
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Fig. 5. Pressure overload induces LV up-regulation of DICER1 in aortic stenosis patients. A: DICER1 mRNA expression (RE) normalized to 18S (***p b 0.001 vs surgical controls, Mann–
Whitney test). Inset: Representative Western blots showing DICER1 expression. B to D: Linear regression and Pearson's correlation analyses showing the positive correlation between
myocardial DICER1 and TGF-β1 mRNA expression (B), SMAD2 (C) and SMAD3 (D). r = Pearson's correlation coefﬁcient.
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tween SMAD2/3 andDICER1 could regulate also thematuration of other
miRs deserves further investigation.
The perinuclear co-localization of DICER1 and p-SMAD2/3-immuno-
ﬂuorescence signals in NIH-3 T3 cells, in primary cardiac ﬁbroblasts and
in LV sections from TACmice further suggests that both proteinsmay be
part of the same functional complex. In situ proximity ligation assays
conﬁrm the existence of a direct protein–protein interaction between
p-SMAD2/3 and DICER1 in NIH-3 T3 cells. In situ proximity ligation as-
says unveil the existence and localization of interactions between two
endogenous proteinswithin the cells [26,27]. Herein, proximity ligation
assays and inmunoﬂuorescence approaches detected p-SMAD2/3/
DICER1 aggregates in the cytosolic perinuclear region of ﬁbroblasts.
This topography is in agreement with the recently proposed idea that
the central steps of RNA silencing by miRNAs, including the processing
of pre-miRNA to mature miRNAs by DICER1, occur at the cytosolic
surface of the rough endoplasmatic reticulum membrane [30-31]. The
accurate production of speciﬁc functional miRNAs requires protein–
protein and protein–RNA interactionsmediated by many accessory fac-
tors that form complexes with either DROSHA and/or DICER1 [32–35].
The mechanisms that regulate miRNA abundance constitute a subject
of active research. The biogenesis of miRNAs is regulated in a complex
manner in response to physiological and pathological stimuli. Mecha-
nisms of transcriptional control are relatively well-known [34], but
modulation of post-transcriptional processing of miRNA precursors ispoorly understooddespite evidence that numerousmiRNAs are regulat-
ed at the posttranscriptional stage [35]. Transient protein complexes,
assembled after signal reception, allow for integration of signaling
events from many pathways, leading to contextual changes in miRNA
expression with the required critical speciﬁcity [35,36]. The ﬁrst study
reporting posttranscriptional regulation of miRNA biogenesis by signal
transducers demonstrated that members of the TGF-β superfamily of
cytokines speciﬁcally promote processing of pri-miR-21 in vascular
smooth muscle cells [23]. TGF-β and BMP signaling induces a rapid in-
crease in mature miR-21 expression by promoting the processing of
pri-miR-21 into pre-miR-21 by the DROSHA microprocessor complex.
The sequence-speciﬁc association of SMADs to the RNA-SMAD binding
elements (R-SBE) within pri-miR-21 provides a platform for micropro-
cessor complex docking and mediates more efﬁcient cleavage by
DROSHA [23–25]. Our present results indicate that p-SMAD2/3 can
also act as accessory factor of DICER1 and suggest that this direct inter-
action facilitates the processing of pre-miR-21 into mature miR-21
(schematic representation in Fig. 7). The location of the R-SBE in the
middle segment of the mature miR-21 sequence [24,25] suggests that
p-SMAD2/3 might serve as an accompanying cofactor throughout the
maturing process of miR-21. p-SMAD2/3 is not the only example in
the literature of RNase cofactors that participate in the posttranscrip-
tional regulation of miRNA biogenesis in both the nucleus and the cyto-
plasm. Transactivation-responsive DNA-binding protein-43 (TDP-43)
facilitates the binding of the DROSHA complex to a subset of pri-
Fig. 6. SMAD2/3 forms a complexwith DICER1 and pre-miR-21. A and A′: Representative in situ hybridization images showingmiR-21 expression in LV primary ﬁbroblasts cultured in the
presence of TGF-β1 (0.3 ng/ml) (A) and negative control (A′). B: Representative confocal immunoﬂuorescence images (merge channel) showing p-SMAD2/3 (red) and DICER1 (green)
co-localization (yellow) in primary cardiac ﬁbroblasts. The arrow indicates the region enlarged in the insets. DICER1 immunoﬂuorescence (green channel) is depicted in grayscale. C: Rep-
resentative LV confocal immunoﬂuorescence images from a TACmouse (merge channel) showing the perinuclear co-localization (yellow) of p-SMAD2/3 (red) and DICER1 (green). The
cell nucleus (blue) lies in the connective tissue that wraps muscle ﬁbers and probably belongs to a ﬁbroblast. The arrow indicates the region of the endomysium enlarged in the insets.
DICER1 (green channel) and p-SMAD2/3 (red channel) immunoﬂuorescences are depicted in grayscale. D: LVmyocardial lysates frommice sham operated or subjected to transverse aor-
tic constriction (TAC) were immunoprecipitated with a SMAD2/3 antibody (IP) or a rabbit IgG (control). Representative images show IP and control samples immunoblotted (IB) for
DICER1 and SMAD2/3. Input: representative western blot of input lysates showing DICER1 expression and GAPDH as loading control. Densitometric analyses of the immunoblots show
DICER1 (E) and SMAD2/3 (F) average expressions in arbitrary units of optical density (AU). G: Densitometric analysis of the input lysates shows DICER1 average expression in AU. H:
MiRNAs were extracted from the IP and subjected to qRT-PCR assay to detect co-precipitation of pre-miR-21 with DICER1 and SMAD2/3. Pre-miR-21 expression was normalized to the
spike-in control cel-miR-39 and relativized to their correspondent controls (*p b 0.05, **p b 0.01 TAC vs sham, Student's t test).
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miRNAs. In the cytoplasm, TDP-43 interacts with the DICER complex
to facilitate the processing of the same pre-miRNAs [37].
TGF-β1 signaling pathways are ﬁnely tuned to orchestrate the gen-
eration of cardiac ﬁbrosis. Heart injury induces TGF-β1 overexpression
that, in turn, activates miR-21 transcription and posttranscriptional
maturation (present results and [23–25]). Most elements of the TGF-β
signaling pathways can be targeted by one or more miRNAs and the ef-
fects of this family of cytokines are highly inﬂuenced by autoregulatory
feedback loops between TGF-β andmiRNAs [30]. The possibility of a di-
rect autoregulatory process of miR-21 and TGF-β is dismissed by the
negative results of TGF-β 3′UTR regulation. We suggest that TGF-β1
transcripts are not directly targeted by miR-21 while the positive con-
trol (3′UTR of SMAD7 mRNA) is inhibited in this cell line [38]. Other
reported remodeling-relatedmiR-21 targets, such as TIMP-3 whose de-
ﬁciency accentuates LV hypertrophy with TAC [39], or TGF-βR2 did not
exhibit any variation in TAC mice, and their expression levels did not
correlate inversely with miR-21 levels, as would be expected for a
miR-target.
Pressure overload of the LV is a clinical condition associated with
pathological entities very prevalent in western countries, such as aortic
valve stenosis or hypertension. Typically, the myocardium develops a
maladaptive response to sustained hemodynamic load, which ischaracterized by cardiomyocyte hypertrophy and interstitial ﬁbrosis.
The development of interstitial ﬁbrosis is a major cause of LV wall stiff-
ening, diastolic and/or systolic dysfunction andprogression to heart fail-
ure [1]. The critical role played by an excessive release of TGF-β in the LV
structural damage produced by biomechanical stress is well known [17,
18]. Several reports support the contribution of miR-21, as downstream
effector of TGF-β, to such pathological ﬁbrotic processes in the AS clini-
cal scenario and in animal models [13–16]. In addition to identifying
SMAD2/3 as DICER1 cofactors to the ﬁne tuning of miR-21 expression,
the present study supports that this regulatory mechanism can have
pathogenetic signiﬁcance in the LV remodeling associatedwith pressure
overload in mice and humans.
The rationale of such statement is based in three major features.
(i) Primary ﬁbroblasts from mouse heart present co-localization of p-
SMAD2/3 andDICER and co-immunoprecipitation–RT-qPCR assays pro-
vide direct evidence for the assembly of DICER1–SMAD2/3 complexes
that co-precipitated in LV myocardial lysates from mice exposed to
TAC. Moreover, the RT-q-PCR performed in the miRNAs extracted
from the immunoprecipitated material evidenced the presence of pre-
miR-21 associated with the DICER1 maturation complex. Compared to
sham, TAC mice exhibited an enhanced association of SMAD2/3 with
DICER1 and pre-miR-21. (ii) DICER1 overexpression was a response of
the heart to the biomechanical stress common to the animal model
Fig. 7. Schematic representation ofmiR-21 processing by DICER1 in the absence or in the presence of p-SMAD2/3 in ﬁbroblasts. The primary transcript pri-miR-21 is processed to the pre-
cursor pre-miR-21,which is translocated to the cytosol to continue its maturation. In the cytoplasm, pre-miR-21 is processed by the ribonuclease DICER1 intomaturemiR-21.We propose
that p-SMAD2/3 potentiates posttranscriptional processing of miR-21 through a direct protein–protein interactionwith DICER1 in the pre-miR-21maturation complex. Thus, the absence
of p-SMAD2/3 in the DICER1 complex would result in reduced production of mature miR-21 and accumulation of the precursor pre-miR-21. In the opposite direction, an increased
presence of p-SMAD2/3 in the DICER1 maturation complex (right panel) would facilitate miR-21 production, reducing the quantity of pre-miR-21.
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up-regulation constitutes an early response to pressure overload.
DICER1 overexpression was also present in the LV from 2-week-
TACmice and in the LV biopsies from surgical patients suffering from se-
vere AS, which suggests that altered biogenesis of miRNAs constitutes a
persistent response to the pressure overload condition, and (iii) DICER1
expression displayed a signiﬁcant positive correlation with genes
encoding TGF-β1 and its major intracellular effectors, SMAD2 and
SMAD3, in the LV myocardium from both TAC mice and AS patients.
The relationship between DICER1 expression and TGF-β signaling mol-
ecules triggered by pressure overload in mice was further supported by
the results of multiple regression analysis showing that the transcript
levels of TGF-β1, SMAD2 and SMAD3 constituted independent predic-
tors which can explain as much as 70% of the variance in DICER1
mRNA levels early after TAC.
We conclude that p-SMAD2/3 controls the posttranscriptional pro-
cessing of miR-21 through a direct proteinprotein interaction between
its canonical transducers p-SMAD2/3 and the ribonuclease DICER1 in
the pre-miR-21 maturation complex (a schematic representation is
depicted in Fig. 7). This new TGFβ-dependent facilitator mechanism
could contribute to the pathogenesis of pressure overload-induced
myocardial remodeling in the mouse model and in patients with aortic
stenosis. In summary, our present ﬁndings contribute to a better under-
standing of themechanism bywhichmiR-21maturation is regulated by
TGF-β signaling, provide further insight into the pathophysiology of
myocardial remodeling and open new avenues of research to ascertain
whether the mechanism described in this manuscript operates also for
other miRNAs and in other diseases.
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